Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:39 ET | 5000 | 1.8501 |
09:41 ET | 100 | 1.9 |
10:03 ET | 300 | 1.935 |
10:06 ET | 1000 | 1.9536 |
10:21 ET | 294 | 1.885 |
10:32 ET | 542 | 1.914 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 49.2M | -1.8x | --- |
Kezar Life Sciences Inc | 42.5M | -0.4x | --- |
Cue Biopharma Inc | 49.6M | -1.0x | --- |
BioLine RX Ltd | 48.8M | -0.7x | --- |
Atara Biotherapeutics Inc | 41.0M | -0.1x | --- |
DURECT Corp | 40.7M | -1.6x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $49.2M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 3.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.